Web Exclusives

May is Skin Cancer Awareness Month! View this slideshow to learn the latest statistics in the United States, leading causes and preventive measures, and quick facts on melanoma, one of the most common types of skin cancer. Conquer cancer with knowledge. Read More ›

NeuVax + Herceptin may provide a clinically meaningful benefit to breast cancer patients with low to intermediate HER2-expression. Read More ›

April is Testicular Cancer Awareness Month! Take a cruise through this slideshow full of facts about testicular cancer, such as the common risk factors and symptoms to look out for. Conquer cancer with knowledge. Read More ›

Lillie Shockney shares a touching, personal story of an experience she had at the Young Survival Coalition Summit, where she held a workshop called “Building Your Legacy." Read More ›

March is Colorectal Cancer Awareness Month! Flip through this slideshow featuring the top risk factors for colorectal cancer, symptoms to look out for, and more. Conquer cancer with knowledge. Read More ›

In patients with HR-positive breast cancer, a positive circulating tumor cells assay result was associated with nearly a 20-fold increased risk for recurrence of disease. Read More ›

Older women with hormone receptor–positive, HER2-negative metastatic breast cancer who are treated with a CDK4/6 inhibitor may derive benefits similar to those seen in their younger counterparts. Read More ›

Treatment with a regimen of pembrolizumab plus trastuzumab in patients with trastuzumab-resistant advanced HER2-positive breast cancer was well-tolerated and had clinical benefit in those whose tumors were positive for a biomarker for pembrolizumab. Read More ›

Patients under age 40 with breast cancer who underwent axillary lymph node dissection were more likely to experience arm swelling and decreased range of arm motion than patients who received less invasive sentinel lymph node biopsies. Read More ›

According to the results of 2 recent analyses, dose-dense or dose-intense chemotherapy reduces the risk for breast cancer recurrence and improves survival compared with standard chemotherapy regimens. Read More ›